Hosted on MSN

LP(a) screening may help detect inherited heart disease risk

A simple blood test for lipoprotein(a), or LP(a), could help identify a major hidden risk for heart attacks and strokes, but many people remain unaware of it, and routine screenings are not yet ...
Medscape

New Test for Lp(a) Allows More Accurate LDL-Cholesterol Results

A new study has drawn attention to inaccurate measurement of LDL-cholesterol levels in some patients with current assays, which could lead to incorrect therapeutic approaches. The patient groups most ...
Yahoo Finance

Roche’s Tina-quant Lp(a) test receives FDA breakthrough device designation

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Medscape

Roche Blood Test for Lp(a) Designated Breakthrough Device

A blood test that measures lipoprotein(a) [Lp(a)] has received breakthrough device designation from the US Food and Drug Administration. The Tina-quant Lp(a) RxDx assay, developed by Roche in ...
Nasdaq

Roche: FDA Grants Breakthrough Device Designation For Bood Test Measuring Lp(a)

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) announced Wedensday that the Tina-quant lipoprotein Lp(a) RxDx assay has received Breakthrough Device Designation from the U.S. Food and Drug ...
Yahoo Finance

Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1 The Roche Diagnostics Tina ...